The most recent trading session ended with Johnson & Johnson (JNJ) standing at $154.42, reflecting a -0.63% shift from the previouse trading day's closing. The stock's change was less than the S&P ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy ...

Johnson & Johnson recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced prostate cancer, which may have influenced its stock's 1.5% rise last week.

CHICAGO - Johnson & Johnson revealed initial results from a Phase 1 trial of its investigational trispecific antibody, JNJ-5322, for treating relapsed or refractory multiple myeloma, with a ...

Johnson & Johnson JNJ announced positive top-line data from a late-stage study evaluating the combination of niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, plus ...

I maintain my buy rating on JNJ, citing attractive valuation, improved technicals, and a raised intrinsic value target of $184 per share. JNJ's recent earnings beat expectations, with strong ...

Over five years ago, the New York Giants were at the start of a new regime in East Rutherford — namely, the first year of the Joe Judge era — and they needed to put together an impactful draft ...

Johnson & Johnson said Wednesday that it is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated ...

Had he not gotten injured in Week 6 of the 2024 schedule, there is a good chance Thomas would have landed in the top 20 players in the pass block win rate category. As soon as he went down, the ...

PIMCO Income Strategy Fund II (PFN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home ...